Hosted on MSN1d
How Chinese biotech firm BGI grew to rival US giant Illumina & enter US-China tariff war
China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...
medtechdive10d
Illumina placed on China’s unreliable entity list
Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...
FierceBiotech11d
Illumina caught in tariff crossfire as China retaliates
The U.S. tariffs on China include a broad 10% levy on imported goods. China’s response was more targeted, with 15% tariffs on ...
Illumina forecasts 2025 revenue largely below estimates
Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...
Healio4d
Stand-alone sequencing identifies hospital pathogen transmission clusters
A stand-alone sequencing approach was accurate, cost effective and efficient for analyzing resistant pathogens and ...
The San Diego Union-Tribune on MSN9d
San Diego’s Illumina placed on China’s ‘unreliable entity list’ following Trump tariffs
The local gene-sequencing company and a U.S. clothing company face sales restrictions in China as part of that country’s ...
Concerns Over China, Trump Funding Cuts Knock Illumina Stock
Illumina shares tumbled 8% Friday on investor concerns about the future of the gene-sequencing equipment maker’s business in ...
Illumina: Regulatory Risk In China And Weaker Sales Rebound Mask A Solid Rebound Of Its Profitability
The placement of Illumina in China's unreliable entity list could have disruptive implications. Read why I remain bullish on ...
Yahoo Finance9d
Illumina forecasts 2025 revenue largely below estimates
(Reuters) - Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling subdued demand for its genetic tests and diagnostic tools ...